Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
130Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $23.85M | $-175.09M | $-2.11 |
| 2024 | $4.14M | $-32.33M | $-0.63 |
| 2023 | $433.0K | $-16.29M | $-0.49 |
| 2022 | $0.00 | $-4.95M | $-0.13 |
| 2021 | $0.00 | $-2.61M | $-0.08 |
Social Signal Score
Earnings
Typical surprise -16.7% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Aug 14$-0.28 vs $-0.17miss
- Wed, May 20$-0.06 vs $-0.06beat
- Fri, Apr 10$-0.84 vs $-0.10miss
- Wed, Nov 19$-0.15 vs $-0.15beat
- Thu, Aug 14$-1.03 vs $-1.03beat
- Tue, May 20$-0.12 vs $-0.12beat
Estimates and results for ASPI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
ASPIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsmarketbeat.com·3d ago·Positive
ASP Isotopes Targets 2026 Deliveries as Helium, Radiopharmacy Expansion Gains Speed ASP Isotopes NASDAQ: ASPI outlined plans to expand its isotope production, radiopharmacy and helium businesses during Canaccord Genuity's 46th Annual Growth Conference, with commercial deliveries of several stable isotopes targeted for the second half of 2026.
View source ↗